Gene: TCAIM
Official Full Name: T cell activation inhibitor, mitochondrialprovided by HGNC
Gene Summary: Located in mitochondrion. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO13521 | TCAIM Knockout cell line (HeLa) | Human | TCAIM | 1:3~1:6 | Negative | Online Inquiry |
KO13522 | TCAIM Knockout cell line (HCT 116) | Human | TCAIM | 1:2~1:4 | Negative | Online Inquiry |
KO13523 | TCAIM Knockout cell line (HEK293) | Human | TCAIM | 1:3~1:6 | Negative | Online Inquiry |
KO13524 | TCAIM Knockout cell line (A549) | Human | TCAIM | 1:3~1:4 | Negative | Online Inquiry |
TCAIM Gene Knockout Cell Lines are specialized cellular models developed for the precise investigation of gene function and therapeutic targeting within biological research. Utilizing advanced CRISPR-Cas9 technology, these cell lines are engineered to exhibit a complete knockout of specific genes, thereby enabling researchers to elucidate the role of those genes in various biological processes, disease mechanisms, and drug responses.
The primary function of TCAIM Gene Knockout Cell Lines lies in their ability to mimic disease states by allowing for the study of gene loss-of-function effects on cellular behavior. This is achieved through the introduction of sequence-specific double-strand breaks in the target genes, which, upon cellular repair, result in insertions or deletions that disrupt normal gene function. As a result, these cell lines provide invaluable insights into pathways involved in cancer, metabolic diseases, and other genetic disorders, making them indispensable tools in the field of functional genomics.
In terms of scientific importance, TCAIM Gene Knockout Cell Lines serve a critical role in both academic and clinical research settings. They facilitate high-throughput screening of therapeutic compounds, reveal potential targets for gene therapy, and enhance our understanding of gene-environment interactions. Standardized and consistent across multiple experiments, these cell lines ensure reproducibility and reliability in research outcomes.
What sets TCAIM Gene Knockout Cell Lines apart from traditional gene editing methods or less sophisticated models is their versatility and precision. They are available for a wide array of genes—extending the capabilities of experimentation—while exhibiting superior stability and minimal off-target effects, which are often challenges in gene knockout studies.
For researchers and clinicians alike, investing in TCAIM Gene Knockout Cell Lines translates into enhanced experimental rigor and the potential for groundbreaking discoveries in genetic research and therapeutic applications. Our company, with its deep-rooted commitment to innovation and excellence in biotechnological advancements, stands ready to support scientific progress with high-quality, reliable biological products tailored to meet research needs.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.